Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
SSTR2 inhibitor
DRUG CLASS:
SSTR2 inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
RYZ101 (2)
ORM-2110 (1)
PEN-221 (1)
177Lu-LNC1010 (0)
EBTATE (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
177Lu-edotreotide (0)
Re (0)
XmAb18087 (0)
RYZ101 (2)
ORM-2110 (1)
PEN-221 (1)
177Lu-LNC1010 (0)
EBTATE (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
177Lu-edotreotide (0)
Re (0)
XmAb18087 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
SSTR2 positive
Neuroendocrine Tumor
SSTR2 positive
Neuroendocrine Tumor
PEN-221
Sensitive: C2 – Inclusion Criteria
PEN-221
Sensitive
:
C2
PEN-221
Sensitive: C2 – Inclusion Criteria
PEN-221
Sensitive
:
C2
SSTR Expression
Neuroendocrine Tumor
SSTR Expression
Neuroendocrine Tumor
ORM-2110
Sensitive: C3 – Early Trials
ORM-2110
Sensitive
:
C3
ORM-2110
Sensitive: C3 – Early Trials
ORM-2110
Sensitive
:
C3
SSTR positive
Neuroendocrine Tumor
SSTR positive
Neuroendocrine Tumor
RYZ101
Sensitive: C3 – Early Trials
RYZ101
Sensitive
:
C3
RYZ101
Sensitive: C3 – Early Trials
RYZ101
Sensitive
:
C3
SSTR2 overexpression
Small Cell Lung Cancer
SSTR2 overexpression
Small Cell Lung Cancer
RYZ101
Sensitive: D – Preclinical
RYZ101
Sensitive
:
D
RYZ101
Sensitive: D – Preclinical
RYZ101
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login